Literature DB >> 8980189

Over-expression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas.

C Chadéneau1, M LeCabellec, B LeMoullac, K Meflah, M G Denis.   

Abstract

Germline mutations of the APC (adenomatous polyposis coli) gene lead to multiple intestinal tumors in familial adenomatous polyposis patients and in Min (multiple intestinal neoplasia) mice. Consequently, these mice provide an excellent model for familial colon cancer. We have identified an Mr approx. 66 kDa glycoprotein which is preferentially expressed at the cell surface of cell lines established from chemically induced rat colon carcinomas. Cloning of the corresponding Tage4 cDNA has revealed that this protein contains the conserved amino acids characteristic of members of the immunoglobulin gene superfamily. Here, we analyze expression of the mouse Tage4 gene in Min mouse intestinal adenomas. RT-PCR analysis allowed us to detect expression of this gene in all the mouse adenomas tested. In contrast, lower levels of Tage4 mRNA were found in the intestinal tract and barely detectable levels in other tissues of normal mice. Furthermore, Tage4 mRNA was detected in a series of mouse intestinal adenomas by in situ hybridization. A strong signal was seen in the samples analyzed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980189     DOI: 10.1002/(SICI)1097-0215(19961211)68:6<817::AID-IJC21>3.0.CO;2-W

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Mapping of two different alpha-1,2-fucosyltransferase genes to rat chromosome 1q22-q31.

Authors:  T Liehr; F Hallouin; B Rautenstrauss; J LePendu; M G Denis
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

2.  αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities.

Authors:  Anastasia N Tikhonova; François Van Laethem; Ken-ichi Hanada; Jinghua Lu; Leonid A Pobezinsky; Changwan Hong; Terry I Guinter; Susanna K Jeurling; Günter Bernhardt; Jung-Hyun Park; James C Yang; Peter D Sun; Alfred Singer
Journal:  Immunity       Date:  2011-12-29       Impact factor: 31.745

3.  Overexpression of the CD155 gene in human colorectal carcinoma.

Authors:  D Masson; A Jarry; B Baury; P Blanchardie; C Laboisse; P Lustenberger; M G Denis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

4.  Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice.

Authors:  Tsukasa Nabekura; Kazuko Shibuya; Eri Takenaka; Hirayasu Kai; Kai Shibata; Yumi Yamashita; Kyoichi Harada; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Akira Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

5.  Aryl Hydrocarbon Receptor Signaling Controls CD155 Expression on Macrophages and Mediates Tumor Immunosuppression.

Authors:  Zachary P McKay; Michael C Brown; Matthias Gromeier
Journal:  J Immunol       Date:  2021-01-27       Impact factor: 5.422

6.  Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3.

Authors:  Tsutomu Fujito; Wataru Ikeda; Shigeki Kakunaga; Yukiko Minami; Mihoko Kajita; Yasuhisa Sakamoto; Morito Monden; Yoshimi Takai
Journal:  J Cell Biol       Date:  2005-10-10       Impact factor: 10.539

7.  Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis.

Authors:  Saori Kakehi; Ken-ichi Nakahama; Ikuo Morita
Journal:  Mol Cell Biochem       Date:  2007-02-08       Impact factor: 3.842

Review 8.  Coming of Age: CD96 Emerges as Modulator of Immune Responses.

Authors:  Hristo Georgiev; Inga Ravens; Georgia Papadogianni; Günter Bernhardt
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

Review 9.  Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.

Authors:  Nadishka Jayawardena; Laura N Burga; John T Poirier; Mihnea Bostina
Journal:  Oncolytic Virother       Date:  2019-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.